KEYMED BIO-B(02162)

38.200-1.000-2.55%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
KEYMED BIO-B
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
- -
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Keymed Biosciences Inc is a China-based biotechnology company. The Company focuses on the independent discovery and development of innovative biological therapies that address underserved medical needs in the autoimmune and oncology therapeutic areas. The Company has mastered in-house drug discovery and development technologies, including an innovative antibody discovery platform and a proprietary novel T cell engager (nTCE) bispecific antibody platform. The Company has also established a fully integrated platform covering the key functions of biopharmaceutical development. The Company's main products include CM310, CM326 and CMG901.

1D
5D
Day
Week
Month

High

39.200

Open

39.200

Volume%

2.22

Low

36.350

Close

39.200

T/O Rate

1.44%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"KEYMED BIO-B(02162),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest KEYMED BIO-B(02162) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"KEYMED BIO-B,02162,KEYMED BIO-B股票,KEYMED BIO-B股票老虎,KEYMED BIO-B股票老虎国际,KEYMED BIO-B行情,KEYMED BIO-B股票行情,KEYMED BIO-B股价,KEYMED BIO-B股市,KEYMED BIO-B股票价格,KEYMED BIO-B股票交易,KEYMED BIO-B股票购买,KEYMED BIO-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"KEYMED BIO-B(02162),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest KEYMED BIO-B(02162) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"summary","symbol":"02162","data":{"stockData":{"symbol":"02162","market":"HK","secType":"STK","nameCN":"KEYMED BIO-B","latestPrice":38.2,"timestamp":1742544503033,"preClose":39.2,"halted":0,"volume":4037400,"delay":0,"floatShares":279735566,"shares":279735566,"eps":-1.472808612003079,"marketStatus":"Market Closed","change":-1,"latestTime":"03-21 16:08:23","open":39.2,"high":39.2,"low":36.35,"amount":152179037,"amplitude":0.072704,"askPrice":38.2,"askSize":500,"bidPrice":38,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":-3.04996317166471,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1742779800000},"marketStatusCode":7,"adr":0,"listingDate":1625673600000,"exchange":"SEHK","adjPreClose":39.2,"openAndCloseTimeList":[[1742520600000,1742529600000],[1742533200000,1742544000000]],"volumeRatio":2.224562088078688,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"stockEarnings":[{"period":"1week","weight":0.0822},{"period":"1month","weight":0.0852},{"period":"3month","weight":0.1718},{"period":"6month","weight":-0.0129},{"period":"1year","weight":0.0523},{"period":"ytd","weight":0.2362}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":0.0325},{"period":"3month","weight":0.2013},{"period":"6month","weight":0.2975},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.1809}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Keymed Biosciences Inc is a China-based biotechnology company. The Company focuses on the independent discovery and development of innovative biological therapies that address underserved medical needs in the autoimmune and oncology therapeutic areas. The Company has mastered in-house drug discovery and development technologies, including an innovative antibody discovery platform and a proprietary novel T cell engager (nTCE) bispecific antibody platform. The Company has also established a fully integrated platform covering the key functions of biopharmaceutical development. The Company's main products include CM310, CM326 and CMG901.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087989},{"month":2,"riseRate":0.75,"avgChangeRate":0.088362},{"month":3,"riseRate":0.25,"avgChangeRate":-0.062556},{"month":4,"riseRate":1,"avgChangeRate":0.048679},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.125967},{"month":6,"riseRate":1,"avgChangeRate":0.150041},{"month":7,"riseRate":0.333333,"avgChangeRate":0.066538},{"month":8,"riseRate":0.5,"avgChangeRate":0.01599},{"month":9,"riseRate":0.75,"avgChangeRate":0.035232},{"month":10,"riseRate":0.5,"avgChangeRate":0.051059},{"month":11,"riseRate":0.5,"avgChangeRate":0.048399},{"month":12,"riseRate":0.25,"avgChangeRate":-0.145383}],"exchange":"SEHK","name":"KEYMED BIO-B","nameEN":"KEYMED BIO-B"},"aProfile":null}}}